title: Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves' disease.
authors.forename: Xin
authors.initials: X
authors.lastname: Wang
authors.forename: Xu-ling
authors.initials: XL
authors.lastname: Xu
authors.forename: Xiu-li
authors.initials: XL
authors.lastname: Zhao
authors.forename: Xiao-wen
authors.initials: XW
authors.lastname: Ma
authors.forename: Hong
authors.initials: H
authors.lastname: Yu
authors.forename: Hui
authors.initials: H
authors.lastname: Gong
authors.forename: Shi-rong
authors.initials: SR
authors.lastname: Zhang
authors.forename: Feng-ling
authors.initials: FL
authors.lastname: Chen
mesh_terms: D000369:Aged, 80 and over; D013956:Antithyroid Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D049970:Graves Ophthalmopathy / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D061386:Insulin, Regular, Human / Q000009:adverse effects* / Q000235:genetics / Q000627:therapeutic use; D008713:Methimazole / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D013956:Antithyroid Agents; D001323:Autoantibodies; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D061386:Insulin, Regular, Human; D011994:Recombinant Proteins; D008713:Methimazole; D011241:Prednisone